---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-23-000005"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2023-02-02T23:59:59+00:00"
generated_at: "2026-06-20T02:57:27.550714+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health Q2 revenue $51.5B, non-GAAP EPS $1.32; raises FY23 guidance

## Summary
- Revenue $51.5B, up 13% YoY; GAAP operating loss $119M on $709M goodwill impairment in Medical segment.
- Non-GAAP diluted EPS $1.32, up 4% YoY; non-GAAP operating earnings $467M, flat YoY.
- Pharmaceutical segment profit $464M (+9%); Medical segment profit $17M (-66%).
- FY23 non-GAAP EPS guidance raised to $5.20-$5.50 from $5.05-$5.40; pharma profit growth outlook raised to 4-6.5%.
- Interest and other lowered to $115M-$130M from $140M-$160M.

## SEC filing metadata
- accession: 0000721371-23-000005
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2023-02-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137123000005/0000721371-23-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137123000005/cah-20230202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-23-000005
- JSON: https://secwatch.observer/filing/0000721371-23-000005.json
- Plain text: https://secwatch.observer/filing/0000721371-23-000005.txt

## Key facts
- Earnings Releases
  CARDINAL HEALTH INC reported results: revenue $51.5 billion, net income GAAP diluted loss per share was $0.50, EPS $1.32. Guidance raised.
  - Revenue: $51.5 billion
  - Net income: GAAP diluted loss per share was $0.50
  - EPS: $1.32
  - Guidance: raised
  - Result: reported results
  source text: Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2023 revenues of $51.5 billion, an increase of 13% from the second quarter of fiscal year 2022. Second quarter GAAP operating loss was $119 million due to a non-cash, pre-tax goodwill impairment of $709 million related to the Medical segment. GAAP diluted loss per share was $0.50, primarily due to this impairment, net of tax effects. Second quarter non-GAAP operating earnings of $467 million were in-line with the second quarter of last year. Non-GAAP diluted earnings per share (EPS) increased 4% to $1.32, due to lower interest expense and a lower share count, partially offset by a higher non-GAAP effective tax rate.
  evidence_url: https://www.sec.gov/Archives/edgar/data/721371/000072137123000005/0000721371-23-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.